tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
US Market
CMMB
Chemomab Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Chemomab Therapeutics (CMMB) Stock News & Sentiment

Compare
252 Followers
Chemomab Therapeutics Announces Annual General Meeting for July 2025
Premium
Company Announcements
Chemomab Therapeutics Announces Annual General Meeting for July 2025
4d ago
6K
CMMB
Chemomab Therapeutics: Promising Prospects with Streamlined Path to Approval and Strategic Advancements
Premium
Ratings
Chemomab Therapeutics: Promising Prospects with Streamlined Path to Approval and Strategic Advancements
14d ago
CMMB
Chemomab Therapeutics Advances Nebokitug for PSC Treatment
Premium
Company Announcements
Chemomab Therapeutics Advances Nebokitug for PSC Treatment
14d ago
CMMB
Chemomab Therapeutics Advances Nebokitug Towards Phase 3 After Positive Trial Results
Premium
Company Announcements
Chemomab Therapeutics Advances Nebokitug Towards Phase 3 After Positive Trial Results
16d ago
6K
CMMB
Chemomab Therapeutics: Promising Phase 2 Data and Attractive Entry Point Justify Buy Rating
Premium
Ratings
Chemomab Therapeutics: Promising Phase 2 Data and Attractive Entry Point Justify Buy Rating
25d ago
CMMB
Chemomab Announces Key Leadership Changes Amid Successful Trial Completion
Premium
Company Announcements
Chemomab Announces Key Leadership Changes Amid Successful Trial Completion
2M ago
6K
CMMB
Promising Phase 3 Prospects and Strategic Study Design Justify Buy Rating for Chemomab Therapeutics
Premium
Ratings
Promising Phase 3 Prospects and Strategic Study Design Justify Buy Rating for Chemomab Therapeutics
2M ago
CMMB
More CMMB News >

CMMB News on the Web

CADL Up as FDA Grants RMAT Status to CAN-2409 in Prostate Cancer
Zacks
Neutral
RCKT Stock Tanks on Patient Death in Danon Disease Study
Zacks
Neutral
TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate
Zacks
Neutral
Chemomab Therapeutics Announces Year End and Fourth Quarter 2024 Financial Results and Provides a Corporate Update
Yahoo Finance
Neutral
Chemomab Completes Successful End-of-Phase 2 Meeting and Aligns with FDA on Clear and Efficient Path to Potential Regulatory Approval for Nebokitug in Primary Sclerosing Cholangitis
Yahoo Finance
Neutral
Chemomab Therapeutics: Promising Clinical Progress and Strategic Regulatory Pathways Support Buy Rating
TipRanks News
Bullish
Chemomab Therapeutics Announces Late-Breaking Oral Presentation of CM-101 Phase 2 Results in Primary Sclerosing Cholangitis at AASLD The Liver Meeting® 2024
Yahoo Finance
Neutral
Chemomab Therapeutics to Present at October 2024 Investor Conferences
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
CMMB
Sector Average
Media Buzz
This Week3 articles
Weekly Average1 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CMMB’s Media Buzz Sentiment?
3 articles about CMMB were published this week. In an average week, 1 articles are published.
    What is CMMB’s weekly average amount of articles?
    In an average week, 1 articles about CMMB are published.
      What is CMMB’s News Sentiment?
      59% of articles about CMMB were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        IVIXFInvion
        PAHCPhibro Animal Health
        COOCooper Co
        VEEVVeeva Systems
        PHRPhreesia
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing